CV:CZO Ceapro Inc.

Ceapro Inc., a biotechnology company, engages in developing and commercializing active ingredients in the United States, Canada, Germany, China, and internationally. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, including Pressurized Gas eXpanded drying technology; and new oat variety and technologies to enhance the content of avenanthramides. The company was founded in 1997 and is headquartered in Edmonton, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol CRPOF.

0.67 CAD
As of 06/18/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  Canada
IPO date:  01/01/1900
Stock exchange:    TSX Venture Exchange
Exchange country:   Canada
Market cap:   52,040,776 CAD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        CA1499071076
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy